Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia

Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV specific neutralizing antibodies were detected for 6 years postinfection.

Automated summary

The study of antibody responses in MERS-CoV infection survivors in Saudi Arabia showed the presence of specific neutralizing antibodies up to 6 years postinfection. This finding provides crucial information for the development of MERS-CoV vaccines.